MYLAN 6727 MYLAN 6727 (Zonisamide 100 mg)
Pill imprint MYLAN 6727 MYLAN 6727 has been identified as Zonisamide 100 mg.
Zonisamide is used in the treatment of migraine prevention; seizures; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 100 mg is not subject to the Controlled Substances Act.
See also related documents.
- 100 mg
- Purple / Blue
- 18.00 mm
- Prescription only
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
sodium lauryl sulfate
FD&C Red No. 3
|NDC Code||Manufacturer / Repackager|
|51079-0768||UDL Laboratories Inc|
|16590-0539||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about zonisamide
- Other brands: Zonegran
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.